ALNY vs EVLVW · P/E 76, rev $1.29B vs rev $29.1M
Alnylam Pharmaceuticals Inc (ALNY) versus Evolv Technologies Holdings Inc (EVLVW) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
Evolv Technologies Holdings Inc (EVLVW) common stock listed on NASDAQ.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported EVLVW revenue for 2024-12-31 was $29.1M. Net income was -$15.7M. Revenue was up 6.4% from 2024-09-30 to 2024-12-31. EVLVW currently screens at market cap $0.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. EVLVW currently screens at market cap $0.
Not investment advice. Open the ALNY and EVLVW stock pages for the full models.
Not investment advice.